Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR) but its impact is not ...

Medtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.

C Medical Technologies has closed its Series D financing round. which was led by Boston Scientific, raising gross proceeds of ...

Rabat - A medical team at the Moulay Youssef Hospital in Rabat successfully performed the country’s first-ever surgery to treat Tricuspid insufficiency, a ...

This month: smelling skills predict stroke risk, insights from LGBTQ+ clinicians, BP screening in public spaces, and more.

Despite proven efficacy and safety of direct oral anticoagulants (DOACs) over warfarin in patients with atrial fibrillation (AF), data on patients with AF and valvular heart disease remain scarce. We ...

The results of the randomized clinical trials (RCTs) that compared DOACs with VKAs for the prevention of thromboembolism in patients defined as non– valvular heart disease (VHD) AF showed that DOACs ...

The study included patients with atrial fibrillation (AF) and valvular heart disease, excluding those with mechanical heart valves. Patients with AF associated with mechanical heart valves and ...

India's first heart failure registry reveals younger patients, high mortality rates, and varying causes of heart failure.

The incidence and prevalence of valvular heart disease (VHD) is increasing and has been described as the next cardiac epidemic. Advances in imaging and therapeutics have revolutionized how we assess ...